Patient experience of venous stenting

  • Research type

    Research Study

  • Full title

    A thematic analysis of patient experience of venous stenting for occlusive iliofemoral DVT

  • IRAS ID

    248622

  • Contact name

    Rebecca Harris

  • Contact email

    rebecca.harris8@uhbristol.nhs.uk

  • Sponsor organisation

    UHBristol Foundation Trust

  • Clinicaltrials.gov Identifier

    N/A, N/A

  • Duration of Study in the UK

    0 years, 4 months, 1 days

  • Research summary

    Deep vein thrombosis (DVT) is a blood clot that forms within a vein in the body, commonly in the leg and abdomen. A DVT can result in complications such as long term pain and swelling and in some cases leg ulcers, this is known as post thrombotic syndrome (PTS). PTS is a debilitating syndrome with patients often experiencing a decreased quality of life (QOL).

    DVT is routinely treated with drug medication; however PTS still affects around 50% of patients despite adequate treatment. A relatively new treatment for DVT is to place a hollow mesh tube, called a stent, inside the vein to hold it open and restore blood flow. Current research shows encouraging results in terms of restoring blood flow. However studies that have assessed symptoms and QOL show mixed results in terms of improvement, often with patients still suffering from PTS after the stent procedure.

    This study aims to assess the patient’s experience of vein stenting rather than focusing on technical success (restoration of blood flow). Participants will be interviewed about their expectations of the treatment, how their leg feels and how the DVT and stent has affected their life. The interviews will be analysed to find themes that appear in the participant interviews. This will help to better understand the complex reality of PTS in this group of patients and the implications of venous stenting on a patient’s life as a whole. The findings will highlight key areas in regards to patient’s QOL that may not be fully addressed within current QOL questionnaires, contributing to the development of a more encompassing way to assess patient outcomes.

  • REC name

    North East - Newcastle & North Tyneside 2 Research Ethics Committee

  • REC reference

    18/NE/0382

  • Date of REC Opinion

    10 Dec 2018

  • REC opinion

    Favourable Opinion